News Search Results
Aug 04, 2025, 10:01 ET (AVAS) Acoustic Vehicle Alerting System Market Experiences 11.6% Growth Owing to Regulatory Mandates & Safety Norms | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 04, 2025, 08:45 ET Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in collaboration with Cleveland Clinic, it has initiated the transfer
More news about: Anixa Biosciences, Inc.
Aug 04, 2025, 08:31 ET MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241
Aug. 4, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research collaboration with Syntekabio, Inc., a leading artificial intelligence
More news about: MetaVia Inc.
Aug 04, 2025, 08:30 ET Cresilon Announces Poster Presentation on TRAUMAGEL Case Study at the 2025 Military Health System Research Symposium
Aug. 4, 2025 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that a case study demonstrating the clinical use of its FDA-cleared hemostatic
More news about: Cresilon
Aug 04, 2025, 08:19 ET Jarlath Keating Joins as President of Solvias Group USA to Drive Growth and Innovation in Advanced Analytical Services
With nearly 30 years of experience in the biopharmaceutical and biotechnology sectors, Mr. Keating brings a robust track record of building high-performing teams, fostering customer-focused innovation, and driving commercial
More news about: Solvias
Aug 04, 2025, 08:00 ET Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
(BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.
More news about: Shilpa Medicare Limited
Aug 04, 2025, 08:00 ET Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
(BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.
More news about: Shilpa Medicare Limited
Aug 04, 2025, 08:00 ET Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
Aug 04, 2025, 07:47 ET Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025
Aug. 4, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system
More news about: Intensity Therapeutics Inc.
Aug 04, 2025, 06:04 ET Tikva Allocell to Participate in Keynote Panel Discussion at Asian Pharma and Biotech Project, Program and Portfolio Management Conference
Tikva Allocell (Tikva), a biotechnology company developing off-the-shelf CAR-T cell therapies for solid tumors, today announced that its Founder and CEO, Dr. Ivan
More news about: Tikva Allocell
Aug 04, 2025, 05:33 ET MGI Tech Hands with Lincoln University to Revolutionize New Zealand Viticulture with Genomics
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Aug 04, 2025, 05:18 ET MGI Tech Hands with Lincoln University to Revolutionize New Zealand Viticulture with Genomics
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Aug 04, 2025, 05:09 ET Aphranel® shines in IMCAS China 2025 as Platinum Sponsor
About Aphranel Aphranel® is a high-profile medical aesthetics brand under Shanghai MOYOM Biotechnology, dedicated to advancing global aesthetics technology through cutting-edge biomaterial innovation.
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
Aug 04, 2025, 03:00 ET Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
(BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.
More news about: Shilpa Medicare Limited
Aug 04, 2025, 02:58 ET Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
advancing innovative cancer therapies and global expansion. About Anbogen Therapeutics Anbogen Therapeutics is a clinical-stage biotechnology company committed to developing precision oncology therapies that improve the lives of cancer patients worldwide. The company currently has two
More news about: Anbogen Therapeutics
Aug 04, 2025, 02:29 ET Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
advancing innovative cancer therapies and global expansion. About Anbogen Therapeutics Anbogen Therapeutics is a clinical-stage biotechnology company committed to developing precision oncology therapies that improve the lives of cancer patients worldwide. The company currently has two
More news about: Anbogen Therapeutics
Aug 04, 2025, 02:29 ET Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease
Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing in its clinical trial of
More news about: Raytone Biotech
Aug 01, 2025, 16:01 ET AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Aug 01, 2025, 13:01 ET Jewellok Unveils Cutting-Edge Specialty Gas Changeover Manifolds to Revolutionize Industrial and Medical Gas Delivery
advanced systems are engineered to provide a continuous and reliable gas supply for critical applications in industries such as semiconductors, biotechnology, pharmaceuticals, and renewable energy. With over a decade of experience in precision fluid management, Jewellok continues to deliver innovative
More news about: Shenzhen Jewellok Technology Co., Ltd
Aug 01, 2025, 11:23 ET Titan of Industry Allan Camaisa Teams Up with Res Nova Bio to Advance Breast Cancer Immunotherapy
Clinical Stage Biotechnology Company Uses Patient Immune System to "Seek and Destroy" Cancer and Metastasis SAN DIEGO, Aug. 1, 2025 /PRNewswire/
More news about: Res Nova Biologics, Inc.
Aug 01, 2025, 10:01 ET 3D Avatar Solution Market is Projected To Reach US$1,234.37 Million By 2031 Due To Significant Growth In E-Commerce And AI, ML, And Real-Time Rendering Innovations | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 01, 2025, 09:00 ET BioMarin Announces Appointment of Ian T. Clark to Board of Directors
Pharmaceuticals, Inc., Avrobio, Inc. and Kite Pharma, Inc. Mr. Clark is currently an advisor to KKR & Co. Inc., and previously served on the board of the Biotechnology Industry Organization, as well as a member of the 12th District Economic Advisory Council of the Federal Reserve. "We are very pleased to
More news about: BioMarin Pharmaceutical Inc.
Aug 01, 2025, 09:00 ET NeuroSense Provides Business Update and Progress for the First Half of 2025
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today provided business update with corporate highlights to date and
More news about: NeuroSense
Aug 01, 2025, 06:30 ET Chromatography Resin Market worth $4.94 billion by 2030 - Exclusive Report by MarketsandMarkets™
Inorganic Media), Technique ((Ion Exchange (Cation and Anion), Affinity (Hydrophobic Interaction, Mixed Mode)), Application (Pharmaceutical & Biotechnology), and Region - Global Forecast to 2030", chromatography resin market size was USD 3.02 billion in 2024 and is projected
More news about: MarketsandMarkets
Aug 01, 2025, 03:52 ET Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease
Aug. 1, 2025 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biotechnology company focused on cellular energy restoration therapeutics, today announced the successful completion of its Phase I clinical trial for ENERGI-F705PD,
More news about: ENERGENESIS BIOMEDICAL CO., LTD.